These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24272837)

  • 1. Kinetic analysis of transdermal nitroglycerin delivery.
    Guy RH; Hadgraft J
    Pharm Res; 1985 Sep; 2(5):206-11. PubMed ID: 24272837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal drug delivery and cutaneous metabolism.
    Guy RH; Hadgraft J; Bucks DA
    Xenobiotica; 1987 Mar; 17(3):325-43. PubMed ID: 3107225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Delivery and Transport into the Central Circulation: An Example of Zero-Order In vivo Absorption of Rotigotine from a Transdermal Patch Formulation.
    Cawello W; Braun M; Andreas JO
    Eur J Drug Metab Pharmacokinet; 2018 Aug; 43(4):475-481. PubMed ID: 29332198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of drug disposition kinetics in skin and plasma following topical administration.
    Guy RH; Hadgraft J
    J Pharm Sci; 1984 Jul; 73(7):883-7. PubMed ID: 6470948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal delivery of contraceptives.
    Friend DR
    Crit Rev Ther Drug Carrier Syst; 1990; 7(2):149-86. PubMed ID: 2272099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin permeability: dermatologic aspects of transdermal drug delivery.
    Kligman AM
    Am Heart J; 1984 Jul; 108(1):200-6. PubMed ID: 6731278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of nitroglycerin and clonidine delivered by the transdermal route.
    Shaw JE
    Am Heart J; 1984 Jul; 108(1):217-23. PubMed ID: 6428208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future drug delivery research in South Korea.
    Chung SJ
    J Control Release; 1999 Nov; 62(1-2):73-9. PubMed ID: 10518638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico prediction of percutaneous absorption and disposition kinetics of chemicals.
    Chen L; Han L; Saib O; Lian G
    Pharm Res; 2015 May; 32(5):1779-93. PubMed ID: 25407547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A theoretical model for transdermal drug delivery from emulsions and its dependence upon formulation.
    Bernardo FP; Saraiva PM
    J Pharm Sci; 2008 Sep; 97(9):3781-809. PubMed ID: 18186500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of a new transdermal nitroglycerin adhesive patch formulation.
    Riedel DJ; Wick KA; Hawkinson RW; Kolars CA; Crowley JK; Armstrong KE; Chang SF; Harrison LI; de Dennis SR
    Clin Ther; 1989; 11(2):225-31. PubMed ID: 2500248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico Modelling of Transdermal and Systemic Kinetics of Topically Applied Solutes: Model Development and Initial Validation for Transdermal Nicotine.
    Chen T; Lian G; Kattou P
    Pharm Res; 2016 Jul; 33(7):1602-14. PubMed ID: 26956458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical considerations of transdermal nitroglycerin delivery: the various approaches.
    Chien YW
    Am Heart J; 1984 Jul; 108(1):207-16. PubMed ID: 6428207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect and Mechanism of Transdermal Penetration Enhancement of Fu's Cupping Therapy: New Physical Penetration Technology for Transdermal Administration with Traditional Chinese Medicine (TCM) Characteristics.
    Xie WJ; Zhang YP; Xu J; Sun XB; Yang FF
    Molecules; 2017 Mar; 22(4):. PubMed ID: 28346390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R; Zia H; Needham TE
    Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma nitroglycerin concentrations and hemodynamic effects of sublingual, ointment, and controlled-release forms of nitroglycerin.
    Curry SH; Kwon HR; Perrin JH; Culp JR; Pepine CJ; Yu WC; Stevens JL
    Clin Pharmacol Ther; 1984 Dec; 36(6):765-72. PubMed ID: 6437723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel pharmacokinetic modelling of transdermal nitroglycerin.
    Auclair B; Sirois G; Ngoc AH; Ducharme MP
    Pharm Res; 1998 Apr; 15(4):614-9. PubMed ID: 9587959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of transdermal drug formulations in the elderly.
    Kaestli LZ; Wasilewski-Rasca AF; Bonnabry P; Vogt-Ferrier N
    Drugs Aging; 2008; 25(4):269-80. PubMed ID: 18361538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of nitroglycerin and of its two metabolites after a single 24-hour application of a nitroglycerin transdermal matrix delivery system.
    Auclair B; Sirois G; Ngoc AH; Ducharme MP
    Ther Drug Monit; 1998 Dec; 20(6):607-11. PubMed ID: 9853974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transdermal delivery of drugs and enhancement of percutaneous absorption].
    Ogiso T; Tanino T
    Yakugaku Zasshi; 2000 Apr; 120(4):328-38. PubMed ID: 10774255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.